Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA -0.4EWJ 0.37TECK.B.TO -2.09CNQ.TO 0.71HHL.TO 0.075SYLD 0.03HAC.TO 0.04TRU -0.01
Labopharm Inc (DDS.TO)

Labopharm Inc (DDS.TO)

0.00
-0.00 (0.00%)
2 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Labopharm Inc(DDS.TO)

Mar 14, 2002
Would have some questions before buying this stock.
Photo of Robert FloydRobert FloydUnlock Rating
$5.00

Stock price when the opinion was issued

biotechnologypharmaceutical
Track your Stocks in your Watch List
BUY

Labopharm Inc(DDS.TO)

Feb 18, 2002
Good product. Has risen very fast and will probably pause for a while. Good price for long term.
Photo of Brendan KyneBrendan KyneUnlock Rating
$9.65

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Labopharm Inc(DDS.TO)

Jan 24, 2002
(Was a top pick on Oct 26 up 50%) Still likes.
Photo of Brendan KyneBrendan KyneUnlock Rating
$10.45

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Labopharm Inc(DDS.TO)

Jan 17, 2002
Agreat future. Lots of risks involved, but the reward should be good. Just completed 2 big deals.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$10.15

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Labopharm Inc(DDS.TO)

Dec 28, 2001
No earnings. Buy on a pull back. Speculation.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$10.85

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Labopharm Inc(DDS.TO)

Dec 24, 2001
Moving up well and should continue.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$11.50

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Labopharm Inc(DDS.TO)

Dec 18, 2001
Making good contracts.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$10.10

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Labopharm Inc(DDS.TO)

Nov 29, 2001
Good partnership. A lot of potential. Pretty high right now.
Photo of Bruce CooperBruce CooperUnlock Rating
$9.49

Stock price when the opinion was issued

biotechnologypharmaceutical
Track your Stocks in your Watch List
TOP PICK

Labopharm Inc(DDS.TO)

Nov 12, 2001
Good product. New agreement is good.
Photo of Brendan KyneBrendan KyneUnlock Rating
$7.94

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Labopharm Inc(DDS.TO)

Oct 26, 2001
Raised $40 million in financing. Good agreements.
Photo of Brendan KyneBrendan KyneUnlock Rating
$7.05

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Labopharm Inc(DDS.TO)

Oct 01, 2001
Has good potential. Low market cap of $160 million. Good mngmnt. Good alliance. Lots of cash.
Photo of Brendan KyneBrendan KyneUnlock Rating
$6.45

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Labopharm Inc(DDS.TO)

Sep 04, 2001
Good alliances.
Photo of Brendan KyneBrendan KyneUnlock Rating
$6.15

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Labopharm Inc(DDS.TO)

Jul 04, 2001
Lots of cash. Good mngmnt.
Photo of Brendan KyneBrendan KyneUnlock Rating
$6.12

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 16 to 28 of 28 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV 0$153.3
WSP.TO 1.13$176.7
VRTX 0.47$452.1
OTEX.TO 0.24$29.47
CCO.TO 0.61$151.07

Today's Top Picks

NVDA -0.4$210.29
EWJ 0.37$96.63
TECK.B.T… -2.09$88.93
CNQ.TO 0.71$58.66
HHL.TO 0.075$6.865

Popular Articles

Latest Sell Signals

TD.TO 0.7$169.33
MBLY -0.03$8.43
ASAN 0.03$6.95
MODG -0.01$18.21
NVTS 0$24.02

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica